missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Viperin Mouse anti-Human, Mouse, Clone: MaP.VIP, Novus Biologicals™
  7. 18611329

Viperin Mouse anti-Human, Mouse, Clone: MaP.VIP, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-07918

 View more versions of this product

Product Code. 18611329

  • 510.00€ / 50µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Viperin Monoclonal antibody specifically detects Viperin in Human, Mouse samples. It is validated for Western Blot, Flow Cytometry, Immunoprecipitation, Immunofluorescence
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Viperin
Monoclonal
0.1 mg/mL
PBS containing 0.1% BSA
Mouse
Protein G purified
RUO
Primary
Human, Mouse
Purified
Western Blot, Flow Cytometry, Immunoprecipitation, Immunofluorescence
MaP.VIP
Unconjugated
2510004L01Rik, cig33, cig5, Cytomegalovirus-induced gene 5 protein, interferon-inducible, radical S-adenosyl methionine domain containing 2, radical S-adenosyl methionine domain-containing protein 2, vig1, Viperin, Virus inhibitory protein, endoplasmic reticulum-associated
Recombinant mouse viperin fragment (residues 92-362)
50 μg
Immunology
91543
Store at 4°C.
IgG2a
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.